Finance

Lists
4119:TPE
SCI Pharmtech Inc
NT$55,70
+0,36%
(+0,20) 1D
1 Okt., 13:30:05 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4119...
Open
NT$55,80
High
NT$55,90
Low
NT$55,10
Mkt. cap
6,66 mjd
Avg. vol.
183,16 k
Volume
65,76 k
Dividend
1,35%
Quarterly dividend
NT$0,19
Ex-dividend date
01 Jul. 2026
P/E ratio
111,12
52-wk high
NT$60,80
52-wk low
NT$39,60
EPS
NT$0,50
Shares outstanding
79,48 m
No. of employees
241
Open
NT$55,80
High
NT$55,90
Low
NT$55,10
Mkt. cap
6,66 mjd
Avg. vol.
183,16 k
Volume
65,76 k
Dividend
1,35%
Quarterly dividend
NT$0,19
Ex-dividend date
01 Jul. 2026
P/E ratio
111,12
52-wk high
NT$60,80
52-wk low
NT$39,60
EPS
NT$0,50
Shares outstanding
79,48 m
No. of employees
241
News stories
From web sources and news partners
About SCI Pharmtech Inc
CEO-
Employees241
Founded1987
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
256,44 m
355,47 m
375,80 m
272,86 m
Cost of goods sold
188,07 m
255,88 m
293,47 m
218,00 m
Cost of revenue
188,07 m
255,88 m
293,47 m
218,00 m
Research and development expenses
8,88 m
9,82 m
9,10 m
10,12 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40,76 m
46,98 m
40,07 m
35,42 m
Operating expense
49,64 m
56,80 m
49,17 m
45,53 m
Total operating expenses
237,71 m
312,67 m
342,65 m
263,53 m
Operating income
18,73 m
42,80 m
33,15 m
9,34 m
Other non operating income
2,31 m
4,19 m
5,32 m
2,52 m
EBT including unusual items
17,80 m
42,28 m
28,59 m
-12,60 m
EBT excluding unusual items
17,84 m
42,23 m
28,56 m
-12,60 m
Income tax expense
3,81 m
3,42 m
8,48 m
248,00 k
Effective tax rate
21,39%
8,10%
29,66%
-1,97%
Other operating expenses
-
-
-
-
Net income
14,00 m
38,86 m
20,11 m
-12,85 m
Net profit margin
5,46%
10,93%
5,35%
-4,71%
Earnings per share
-
-
-
-
Interest and investment income
789,00 k
578,00 k
1,00 k
359,00 k
Interest expense
-1,12 m
-1,81 m
-2,08 m
-2,51 m
Net interest expenses
-336,00 k
-1,23 m
-2,08 m
-2,15 m
Depreciation and amortization charges
-
-
-
-
EBITDA
80,72 m
104,97 m
95,55 m
72,04 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme